Korro Bio, Inc.·4

Apr 1, 9:46 PM ET

Vincent Loic A 4

4 · Korro Bio, Inc. · Filed Apr 1, 2025

Insider Transaction Report

Form 4
Period: 2025-04-01
Vincent Loic A
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-01+70,00070,000 total
    Exercise: $15.95Exp: 2035-03-30Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest as to 25% of the shares on March 31, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date

Documents

1 file
  • 4
    ownership.xmlPrimary

    4